Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spruce Biosciences (SPRB) Consolidated Net Income (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Consolidated Net Income for 4 consecutive years, with -$11.1 million as the latest value for Q4 2025.

  • Quarterly Consolidated Net Income rose 52.69% to -$11.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$35.5 million through Dec 2025, up 33.13% year-over-year, with the annual reading at -$35.5 million for FY2025, 33.13% up from the prior year.
  • Consolidated Net Income for Q4 2025 was -$11.1 million at Spruce Biosciences, down from -$8.2 million in the prior quarter.
  • The five-year high for Consolidated Net Income was -$2.1 million in Q2 2025, with the low at -$23.6 million in Q4 2024.
  • Average Consolidated Net Income over 4 years is -$11.4 million, with a median of -$11.5 million recorded in 2022.
  • The sharpest move saw Consolidated Net Income crashed 136.77% in 2024, then soared 77.49% in 2025.
  • Over 4 years, Consolidated Net Income stood at -$11.1 million in 2022, then grew by 10.71% to -$10.0 million in 2023, then crashed by 136.77% to -$23.6 million in 2024, then soared by 52.69% to -$11.1 million in 2025.
  • According to Business Quant data, Consolidated Net Income over the past three periods came in at -$11.1 million, -$8.2 million, and -$2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.